Aardvark Therapeutics (AARD) Shares Outstanding (Diluted) (2024 - 2026)
Aardvark Therapeutics' Shares Outstanding (Diluted) came in at 21.85 million for Q2 2026, up 0.7% from 21.69 million a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Aardvark Therapeutics (AARD) Shares Outstanding (Diluted) (2024 - 2026) Analysis & Trends
For FY2025, Aardvark Therapeutics' Shares Outstanding (Diluted) was 19.62 million, up 391.1% from FY2024.
- Going back by year, Shares Outstanding (Diluted) was 4 million in FY2024.
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Diluted) in data going back to Q1 2024.
- Year-over-year, Shares Outstanding (Diluted) has increased for six consecutive quarters, with growth averaging 263.5% over the last six quarters.
- Business Quant data shows AARD's Shares Outstanding (Diluted) at 21.82 million (Q1 2026), 19.62 million (Q4 2025) and 21.71 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Aardvark Therapeutics | 115.33 Mn | 41.43 Mn | - | 21.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.85 Mn |
| Mar 31, 2026 | 21.82 Mn |
| Dec 31, 2025 | 19.62 Mn |
| Sep 30, 2025 | 21.71 Mn |
| Jun 30, 2025 | 21.69 Mn |
| Mar 31, 2025 | 13.19 Mn |
| Dec 31, 2024 | 4.00 Mn |
| Sep 30, 2024 | 3.99 Mn |
| Jun 30, 2024 | 3.97 Mn |
| Mar 31, 2024 | 3.97 Mn |
API Access
Aardvark Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AARD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "AARD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=AARD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();